Outlook Therapeutics (OTLK) Research & Development (2015 - 2026)
Outlook Therapeutics' Research & Development was $3.25 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 54.4% from $7.13 million a year earlier and down 27.8% from the prior quarter.
Outlook Therapeutics (OTLK) Research & Development (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Outlook Therapeutics' Research & Development was $17.36 million through Jun 30, 2026, down 48.5% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $27.18 million, down 34.9% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 0.6% (FY2020 to FY2025).
- In earlier fiscal years, Research & Development was $41.76 million in FY2024 (+57.9%), $26.45 million in FY2023 (-37.5%), $42.33 million in FY2022 (+8.7%) and $38.96 million in FY2021 (+47.9%).
- The fiscal Q3 2026 figure marks the lowest quarterly Research & Development since fiscal Q2 2023.
- Compared with a year earlier, Research & Development was higher in three of the last eight quarters, with an average decline of 0.5%.
- The best year-over-year quarter for Research & Development over five years was fiscal Q4 2024 (growth of 153.3%); the worst was fiscal Q2 2023 (a decline of 95.5%).
- Per Business Quant data, OTLK's Research & Development in the three fiscal quarters before Q3 2026 was $4.5 million (Q2 2026), $3.63 million (Q1 2026) and $5.98 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Outlook Therapeutics | 84.78 Mn | 49.03 Mn | -8,265.00 | 3.25 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.25 Mn |
| Mar 31, 2026 | 4.50 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Sep 30, 2025 | 5.98 Mn |
| Jun 30, 2025 | 7.13 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 9.66 Mn |
| Sep 30, 2024 | 12.52 Mn |
| Jun 30, 2024 | 11.20 Mn |
| Mar 31, 2024 | 13.51 Mn |
| Dec 31, 2023 | 4.53 Mn |
| Sep 30, 2023 | 4.94 Mn |
| Jun 30, 2023 | 11.10 Mn |
| Mar 31, 2023 | 544,948.00 |
| Dec 31, 2022 | 9.86 Mn |
| Sep 30, 2022 | 8.99 Mn |
| Jun 30, 2022 | 11.25 Mn |
| Mar 31, 2022 | 12.22 Mn |
| Dec 31, 2021 | 9.87 Mn |
| Sep 30, 2021 | 9.93 Mn |
Outlook Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();